PFE
Pfizer Inc
NYSE: PFE · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$26.70
+1.68% today
Updated 2026-04-29
Market cap
$149.38B
P/E ratio
19.31
P/S ratio
2.39x
EPS (TTM)
$1.36
Dividend yield
6.50%
52W range
$21 – $29
Volume
37.7M
Pfizer Inc (PFE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $17.59B | $13.35B | $18.24B | $16.59B | $11.45B | $20.24B | $17.05B | $17.77B | $16.88B | $14.51B | $15.90B | $16.47B | $15.83B | $12.59B | $14.40B | $32.58B | $29.27B | $8.70B | $12.74B | $11.71B |
| Capital expenditures | $2.05B | $1.88B | $1.70B | $1.21B | $1.51B | $1.66B | $1.33B | $1.47B | $1.58B | $1.50B | $2.00B | $2.22B | $2.20B | $2.59B | $2.79B | $2.71B | $3.24B | $3.91B | $2.91B | $2.63B |
| Depreciation | $5.29B | $5.20B | $5.09B | $4.76B | $8.49B | $9.03B | $7.61B | $6.41B | $5.54B | $5.16B | $5.76B | $6.27B | $6.38B | $6.01B | $4.78B | $5.19B | $5.06B | $6.29B | $7.01B | — |
| Stock-based comp | $-10.48B | $-158.00M | $-20.00M | $349.00M | $405.00M | $419.00M | $481.00M | $523.00M | $586.00M | $669.00M | $691.00M | $840.00M | $949.00M | $718.00M | $756.00M | $1.18B | $872.00M | $525.00M | $877.00M | $799.00M |
| Free cash flow | $15.54B | $11.47B | $16.54B | $15.38B | $9.94B | $18.58B | $15.73B | $16.30B | $15.30B | $13.02B | $13.90B | $14.25B | $13.63B | $9.99B | $11.61B | $29.87B | $26.03B | $4.79B | $9.84B | $9.08B |
| Investing cash flow | $5.10B | $795.00M | $-12.84B | $-31.27B | $-492.00M | $2.20B | $6.15B | $-10.63B | $-5.65B | $-2.98B | $-7.81B | $-4.74B | $4.53B | $-3.94B | $-4.27B | $-22.55B | $-15.78B | $-32.28B | $2.65B | — |
| Financing cash flow | $-23.10B | $-12.61B | $-6.56B | $14.48B | $-11.17B | $-20.61B | $-16.00B | $-14.97B | $-9.99B | $-10.23B | $-8.92B | $-13.04B | $-20.44B | $-8.48B | $-9.65B | $-9.82B | $-14.83B | $26.07B | $-17.14B | — |
| Dividends paid | $6.92B | $7.97B | $8.54B | $5.55B | $6.09B | $6.23B | $6.53B | $6.58B | $6.61B | $6.94B | $7.32B | $7.66B | $7.98B | $8.04B | $8.44B | $8.73B | $8.98B | $9.25B | $9.51B | $9.77B |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-144.00M | $-243.00M | $1.80B | $7.21B | $-7.90B | $1.16B | $298.00M | $-1.05B | $-1.25B | $-89.00M | $158.00M | $483.00M | $218.00M | $-1.35B | — | — | — |